loading
前日終値:
$1.155
開ける:
$1.14
24時間の取引高:
2,252
Relative Volume:
0.08
時価総額:
$41.02M
収益:
-
当期純損益:
-
株価収益率:
-3.3611
EPS:
-0.3481
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
-12.69%
6か月 パフォーマンス:
-10.69%
1年 パフォーマンス:
-63.23%
1日の値動き範囲:
Value
$1.14
$1.17
1週間の範囲:
Value
$1.10
$1.20
52週間の値動き範囲:
Value
$0.85
$4.40

Akari Therapeutics Plc Adr Stock (AKTX) Company Profile

Name
名前
Akari Therapeutics Plc Adr
Name
セクター
Healthcare (1160)
Name
電話
(646) 350-0702
Name
住所
22 BOSTON WHARF ROAD, BOSTON
Name
職員
12
Name
Twitter
@AkariTX
Name
次回の収益日
2024-04-29
Name
最新のSEC提出書
Name
AKTX's Discussions on Twitter

AKTX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.17 41.02M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Akari Therapeutics Plc Adr Stock (AKTX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2019-01-04 アップグレード B. Riley FBR Neutral → Buy
2018-02-08 開始されました B. Riley FBR, Inc. Neutral
2017-09-22 アップグレード William Blair Mkt Perform → Outperform
2017-05-31 アップグレード Chardan Capital Markets Sell → Neutral
2017-04-17 繰り返されました Chardan Capital Markets Sell
2016-07-11 開始されました Chardan Capital Markets Sell
すべてを表示

Akari Therapeutics Plc Adr (AKTX) 最新ニュース

pulisher
Jun 18, 2025

Akari Therapeutics secures Indian patent for cancer drug payload - Investing.com India

Jun 18, 2025
pulisher
May 17, 2025

Akari Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 17, 2025
pulisher
May 01, 2025

Akari Therapeutics appoints new head of oncology business By Investing.com - Investing.com India

May 01, 2025
pulisher
May 01, 2025

Akari Therapeutics appoints new head of oncology business - Investing.com

May 01, 2025
pulisher
Apr 17, 2025

Akari Therapeutics Advances ADC Development Amid Financial Challenges - TipRanks

Apr 17, 2025
pulisher
Mar 20, 2025

Akari Therapeutics names new CEO to drive cancer drug innovation - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Akari Therapeutics names new CEO to drive cancer drug innovation By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Ibotta Inc (IBTA) Shares Soar Above 1-Year High - The News Heater

Mar 20, 2025
pulisher
Mar 20, 2025

Akari Therapeutics Appoints New CEO, Current CEO to Step Down By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Akari Therapeutics Appoints New CEO, Current CEO to Step Down - Investing.com

Mar 20, 2025
pulisher
Mar 03, 2025

Akari Therapeutics secures $7.6 million in private placement - Investing.com India

Mar 03, 2025
pulisher
Feb 03, 2025

Major ADC Developer Akari Opens Direct Channel to Investors Through Webull Platform - StockTitan

Feb 03, 2025
pulisher
Dec 18, 2024

Akari Therapeutics appoints new CEO and board member - Investing.com

Dec 18, 2024
pulisher
Dec 16, 2024

AKTXAkari Therapeutics plc ADR (0.01 USD) Latest Stock News & Market Updates - StockTitan

Dec 16, 2024
pulisher
Dec 16, 2024

Akari Therapeutics Strengthens Leadership: Former CFO Returns After $50M Fundraising Success - StockTitan

Dec 16, 2024
pulisher
Nov 19, 2024

Akari Therapeutics Regains Nasdaq Compliance, Secures Market Listing Status - StockTitan

Nov 19, 2024
pulisher
Nov 14, 2024

Akari Therapeutics Completes Peak Bio Merger, Secures $53.2M in Financing Commitments - StockTitan

Nov 14, 2024
pulisher
Nov 08, 2024

Akari Therapeutics shareholders approve Peak Bio merger - Investing.com

Nov 08, 2024
pulisher
Oct 05, 2024

Akari Therapeutics Plc faces Nasdaq delisting over equity shortfall - Investing.com India

Oct 05, 2024
pulisher
Jun 05, 2024

Akari Therapeutics Announces Interim CEO Employment Contract Demonstrating Alignment with Shareholders - StockTitan

Jun 05, 2024
pulisher
Sep 29, 2023

Akari Therapeutics Reports First Half 2023 Financial Results and Highlights - StockTitan

Sep 29, 2023
pulisher
Apr 11, 2023

Akari Therapeutics to Attend ARVO 2023, the Annual Meeting of The Association for Research in Vision and Ophthalmology - StockTitan

Apr 11, 2023
pulisher
Mar 30, 2023

Akari Therapeutics, Plc Announces $4 Million Registered Direct Offering - StockTitan

Mar 30, 2023
pulisher
Nov 04, 2022

Peak Bio (PKBO) Stock Price, News & Analysis - MarketBeat

Nov 04, 2022
pulisher
Jan 20, 2021

The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Yahoo Finance

Jan 20, 2021
pulisher
Jan 02, 2017

Akari Therapeutics PLC Stock Price Today | NASDAQ: AKTX Live - Investing.com

Jan 02, 2017
pulisher
Aug 18, 2016

Angion Biomedica (ANGN) Stock Price, News & Analysis - MarketBeat

Aug 18, 2016
pulisher
Jul 27, 2011

ADVFN | Live Stock, Options & Crypto Market Data, Trading Tools & Community - ADVFN

Jul 27, 2011

Akari Therapeutics Plc Adr (AKTX) 財務データ

Akari Therapeutics Plc Adr (AKTX) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Akari Therapeutics Plc Adr (AKTX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Gaslightwala Abizer
President & CEO
Jun 23 '25
Buy
1.15
943
1,084
272,371
Gaslightwala Abizer
President & CEO
Jun 20 '25
Buy
1.20
10,000
12,000
271,428
Gaslightwala Abizer
President & CEO
Jun 17 '25
Buy
1.20
15,000
18,000
261,428
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
大文字化:     |  ボリューム (24 時間):